Zydus Lifesciences informs about press release

13 Nov 2025 Evaluate
Zydus Lifesciences has informed that it enclosed a copy of press release dated November 13, 2025, titled ‘Zydus receives final approval from USFDA for Diroximel Fumarate Delayed-Release Capsules, 231 mg’.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

904.85 -15.95 (-1.73%)
13-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1698.10
Dr. Reddys Lab 1267.60
Cipla 1330.85
Zydus Lifesciences 904.85
Lupin 2199.20
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×